Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Massage Impact on Sleep in Pediatric Oncology

NCT06892158

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Acute Myeloid Leukemia, Cancer, +16 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

NCT03398161

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

NCT07523737

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Beijing Tongren Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

NCT07356245

Conditions: Adult T-Cell Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, Graft Versus Host Disease, +25 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

NCT06839456

Conditions: Acquired Aplastic Anemia, Anemia, Anemia, Refractory, +35 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

NCT05336383

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

NCT07107529

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: IT-Ascoli Piceno-Ospedale Mazzoni [01-016] Ascoli Piceno, Italy

IT-Bari-A.O.U. Consorziale Policlinico - Medicina Interna [01-018] Bari, Italy

IT-Bergamo-A.O. Papa Giovanni XXIII [01-003] Bergamo, Italy

IT-Bologna-A.O.U. di Bologna - Policlinico S. Orsola Malpighi [01-004] Bologna, Italy

View all 29 locations

View Trial Details

Recruiting

Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia

NCT07499349

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Recruiting

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

NCT04491370

Conditions: B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +27 more
Locations: New York Medical Center Valhalla, New York, United States

View Trial Details

Recruiting

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

NCT05996185

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
Locations: Yale Cancer Center, Clinical Trials Office New Haven, Connecticut, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions